Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Plant Response Inc. maintains a company patent portfolio within the Biotechnology & Pharmaceuticals sector. Currently, the portfolio includes 2 pending office actions. This workload is handled by 2 distinct examiners, including WELLES, COLMAN THOMAS, who is the busiest examiner with 1 busiest examiner pending action. All prosecution activity is localized within 2 distinct art units.
For a practitioner, this distribution means the company's current USPTO engagement is spread across multiple technical channels. The 2 pending office actions represent the entirety of the active pipeline. Navigating the Biotechnology & Pharmaceuticals field with 2 distinct examiners allows for a distributed approach to prosecution. However, it also means the portfolio's immediate growth depends on the resolution of the 1 busiest examiner pending action. Practitioners should tailor their strategy specifically to the tendencies of WELLES, COLMAN THOMAS to optimize outcomes within the 2 distinct art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLES, COLMAN THOMAS | 1 | 26.9% | +65.7% |
| JONES-FOSTER, ERICA NICOLE | 1 | 49.4% | +44.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006881 | METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND PROTECTION | WELLES, COLMAN THOMAS | 5d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18006881 | METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND PROTECTION | WELLES, COLMAN THOMAS | 5d |
| 17786111 | METHODS AND SYSTEMS FOR PATHOGEN MITIGATION IN ORGANIC MATERIALS | JONES-FOSTER, ERICA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18006881 | METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND PROTECTION | WELLES, COLMAN THOMAS | 1612 | §102§103 | Non-Final OA | 5d | Pending | Jan 26, 2023 |
| 17786111 | METHODS AND SYSTEMS FOR PATHOGEN MITIGATION IN ORGANIC MATERIALS | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | — | Pending | Jun 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPlant Response Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Colman Thomas Welles has the most, with 1 of Plant Response Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
